Novel therapeutic strategies for advanced ovarian cancer by using induced pluripotent stem cell‐derived myelomonocytic cells producing interferon beta

Although first‐line chemotherapy has a high rate of complete responses in ovarian cancer patients, the vast majority of patients present with recurrent disease that has become refractory to conventional chemotherapy. Peritoneal dissemination and malignant ascites are the hallmarks of recurrent or ad...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Sci
Egile Nagusiak: Imamura, Yuko, Tashiro, Hironori, Tsend‐Ayush, Gandolgor, Haruta, Miwa, Dashdemberel, Narantuya, Komohara, Yoshihiro, Tsuboki, Junko, Takaishi, Kiyomi, Ohba, Takashi, Nishimura, Yasuharu, Katabuchi, Hidetaka, Senju, Satoru
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2018
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6215869/
https://ncbi.nlm.nih.gov/pubmed/30142694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13775
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak